Dr Gottlieb's quarterly progress report: more FDA staff and more generics

Pharma breathed a sigh of relief when, after months of strident rhetoric damning the industry, President Trump picked industry insider Scott Gottlieb as the new FDA Commissioner.

"Thank God it's Gottlieb" was one analyst’s reaction to the news.

But three months since his appointment was ratified by the US Senate, what has Dr Gottlieb done, and have his actions justified the faith placed in him by the industry?